China SXT Pharmaceuticals (SXTC) Current Leases (2023 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Current Leases of $67979.0 for Q1 2026, up 11.02% year-over-year from $61229.0 in Q1 2025, and up 6.02% quarter-over-quarter from $64118.0 in Q3 2025.
China SXT Pharmaceuticals (SXTC) Current Leases (2023 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Current Leases history runs 4 years deep, the most recent figure standing at $67979.0 for Q1 2026.
- In Q1 2026, Current Leases rose 11.02% year-over-year to $67979.0; the TTM figure through Mar 2026 stood at $67979.0 (up 11.02% YoY), while the FY2026 annual figure was $67979.0, up 11.02% from the prior year.
- Current Leases for Q1 2026 stood at $67979.0, up from $64118.0 in the prior quarter.
- The five-year high for Current Leases was $67979.0 in Q1 2026, with the low at $56171.0 in Q3 2023.
- The 4-year median for Current Leases is $61229.0 (2025), against an average of $61430.6.
- The sharpest annual moves came in 2024 and 2025: Current Leases advanced 14.15% in 2024, then changed 0.0% in 2025.
- China SXT Pharmaceuticals' Current Leases stood at $56171.0 in 2023, then advanced by 14.15% to $64118.0 in 2024, then changed by 0.0% to $64118.0 in 2025, then rose by 6.02% to $67979.0 in 2026.
- Business Quant data shows SXTC's Current Leases at $67979.0 in Q1 2026, $64118.0 in Q3 2025, and $61229.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | China SXT Pharmaceuticals | 32,922.00 | -28.14 Mn | - | 67,979.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 67,979.00 |
| Sep 30, 2025 | 64,118.00 |
| Mar 31, 2025 | 61,229.00 |
| Sep 30, 2024 | 64,118.00 |
| Mar 31, 2024 | 58,310.00 |
| Sep 30, 2023 | 56,171.00 |
| Mar 31, 2023 | 58,089.00 |